key: cord-0880248-nkfang3k
authors: Fernández‐Penny, Felix E.; Jolkovsky, Eliana L.; Shofer, Frances S.; Hemmert, Keith C.; Valiuddin, Hisham; Uspal, Julie E.; Sands, Nathaniel A.; Abella, Benjamin S.
title: COVID‐19 Vaccine Hesitancy Among Patients in Two Urban Emergency Departments
date: 2021-08-17
journal: Acad Emerg Med
DOI: 10.1111/acem.14376
sha: 541c262566c8d36b6ec1ba1016787484049984a0
doc_id: 880248
cord_uid: nkfang3k

BACKGROUND: Widespread vaccination is an essential component of the public health response to the COVID‐19 pandemic, yet vaccine hesitancy remains pervasive. This prospective survey investigation aimed to measure the prevalence of vaccine hesitancy in a patient cohort at two urban Emergency Departments (EDs) and characterize underlying factors contributing to hesitancy. METHODS: Adult ED patients with stable clinical status (Emergency Severity Index 3‐5) and without active COVID‐19 disease or altered mental status were considered for participation. Demographic elements were collected, as well as reported barriers/concerns related to vaccination and trusted sources of health information. Data were collected in‐person via a survey instrument proctored by trained research assistants. RESULTS: 1,555 patients were approached, and 1,068 patients completed surveys (completion rate 68.7%). Mean age was 44.1 y (SD 15.5, range 18‐93), 61% were female, and 70% were Black. 31.6% of ED patients reported vaccine hesitancy. Of note, 19.7% of the hesitant cohort were healthcare workers. In multivariable regression analysis, Black race (OR 4.24, 95%CI 2.62‐6.85) and younger age (age 18‐24 y, OR 4.57, 95%CI 2.66‐7.86; age 25‐35 y, OR 5.71, 95% CI 3.71‐8.81) were independently associated with hesitancy, to a greater degree than level of education (high school education or less, OR 2.27, 95%CI 1.23‐4.19). Hesitant patients were significantly less likely to trust governmental sources of vaccine information than non‐hesitant patients (39.6% vs 78.9%, p<0.001); less difference was noted in the domain of trust towards friends/family (51.1% vs. 61.0%, p=0.004). Hesitant patients also reported perceived vaccine safety concerns and perceived insufficient research. CONCLUSIONS: Vaccine hesitancy is common among ED patients, and more common among Black and younger patients, independent of education level. Hesitant patients report perceived safety concerns and low trust in government information sources, but less so friends or family. This suggests strategies to combat hesitancy may need tailoring to specific populations.

Coronavirus disease 2019 has claimed the lives of more than 600,000 Americans since March 2020, and incidence in the U.S. is rising with the appearance of the strain known as the delta variant. 1 The severity of the pandemic underscores the importance of successful administration of FDA-authorized vaccines; however, vaccine hesitancy poses a significant threat to these efforts. In 2019 the World Health Organization characterized vaccine hesitancy among the "Top Ten Threats to Global Health". 2 Vaccine hesitancy may be especially prevalent among specific populations, including racial and ethnic minorities who have been disproportionately impacted by the pandemic and are made more vulnerable to continued viral transmission by lower vaccination rates. 3 An important opportunity to address vaccine hesitancy lies in Emergency Departments (EDs) that serve minority and under-resourced communities that may experience either increased levels of vaccine hesitancy and/or restricted access to vaccination. Such EDs often represent communities with high COVID-19 disease burdens and limited healthcare access. As such, EDs may represent valuable sites for vaccine education and even direct vaccination efforts. [4] [5] [6] While recent studies have assessed hesitancy and barriers to uptake in the general population, [7] [8] [9] [10] [11] there are limited data from ED patient populations. Quantitative data on vaccine hesitancy in ED patient cohorts, and health information perspectives of ED patients are especially important as the ED often represents the primary point of healthcare contact for many such patients. We sought to quantify and characterize vaccine hesitancy among a cohort of ED patients in two urban academic medical centers and to assess perceived barriers and trusted sources of health information.

Between 01/29/21 -05/11/21 patients were enrolled in the EDs of the Hospital of the University of Pennsylvania (HUP) and Penn Presbyterian Medical Center (PPMC), both tertiary academic hospitals in Philadelphia. All adult patients without evident critical illness were considered for eligibility. Exclusion criteria included: (1) age <18 years, (2) triage Emergency Severity Index (ESI) category of either 1 (immediate resuscitation), or 2 (emergent condition), (3) laboratory-

confirmed COVID-19 disease at ED presentation, (4) altered mental status or impairments otherwise precluding their ability to consent, and (5) active droplet or isolation precautions. University of Pennsylvania Institutional Review Board approval was granted to conduct this study with written informed consent from study participants.

After informed consent, a questionnaire was administered and proctored in-person by trained research staff. Subjects' responses were documented in real-time via an electronic, HIPAA-compliant clinical database (REDCap, Vanderbilt University, TN). 31 responses for which a majority of the survey fields were left incomplete were excluded from subsequent statistical analyses. Upon completion of the study questionnaire, participants were given a COVID-19 vaccine resource document providing abbreviated information on the development, mechanism, and availability of each of the FDA-approved vaccines.

The study questionnaire solicited personal and household demographic elements, as well as other COVID-19-pertinent indicators such as perceived immunocompromised status, personal and close-contact COVID-19 diagnosis history, and for those with a laboratory-confirmed positive result, whether treatment included hospitalization. Vaccine hesitancy was assessed, defined by answering "no" to the question, "If one of the FDA-approved COVID-19 vaccines becomes readily available to you, would you be willing to receive it?". Participants were also presented Likert-scale prompts to assess potential barriers to vaccine uptake and/or factors influencing hesitancy, organized into three overarching groups: 7 statements assessing confidence in vaccine science, 5 statements assessing trusted health/vaccine information sources, and 6 statements assessing spheres of influence affecting vaccine decision-making. Likert prompts were ranked on a 5-point scale, each including a neutral opinion choice (3) . Statements in the confidence in vaccine science group were ranked from 1 (strongly agree) to 5 (strongly disagree). Those in the trusted health/vaccine information sources group were ranked from 1 (strongly trust) to 5 (strongly distrust) and those in the spheres of influence affecting vaccine decision-making group were ranked from 1 (strongly influence to accept vaccination) to 5 (strongly discourage from accepting a vaccine).

Survey questions, including their organization and wording, were designed leveraging existing survey-based vaccine hesitancy research instruments and their findings, [7] [8] [9] [10] [11] and then subjected to beta testing in a preliminary ED cohort before finalization of the instrument. All study staff received Accepted Article training in questionnaire administration, and data were periodically reviewed by designated lead coordinators as a quality assurance mechanism.

Summary statistics (frequencies and percentages) are presented for respondent characteristics (e.g. gender, race, age, education, etc.). For each survey question (including demographics), only the percent of respondents who answered the survey question was tabulated, excluding question left blank or answered unsure. To compare respondents willing to receive the vaccine versus those who were hesitant, Fisher's exact test were used. For analysis purposes, Likert scale questions were dichotomized and Fisher's exact tests performed to assess differences in confidence in vaccine science, trusted information sources, and spheres of influence between vaccine willing and hesitant groups. To assess which demographic factors independently predict vaccine hesitancy, multivariable logistic regression models were developed. A probability less than .05 was considered statistically significant. All analyses were performed using statistical software (SAS version 9.4, SAS Institute, Cary, NC). Manuscript preparation was conducted following the EQUATOR-indexed guidelines for survey studies, specifically the Consensus-Based Checklist for Reporting of Survey Studies (CROSS). 12

1,555 patients were approached for participation. Of the 1,111 respondents who provided informed consent, 1,068 (96%) sufficiently completed study questionnaires, yielding an overall completion rate of 68.7%. The respondents were 61% female, 70% Black, with mean age 44.1 y (SD 15.5). Terminal education level high school or below was reported by 46% of respondents; 43% reported at least partial college education and 11% reported post-college level education. 55% of subjects were enrolled at the PPMC ED, and 45% in the HUP ED. Cohort demographics are shown in Table 1 .

Vaccine hesitancy was reported by 31.6% of the total cohort. When dichotomized by presence or absence of hesitancy ( 

This article is protected by copyright. All rights reserved with hesitancy, with the measured difference between hesitant and willing groups diverging further as the number of additional household members increased (6% difference with 1-2 additional members vs. 10% difference with 3 or more, p=0.007). Insurance type was also associated with vaccine hesitancy, with those on government insurance plans reporting greater hesitancy than those on private or commercial plans (57.9% vs. 42.1%, p<0.001). Neither an established relationship with a primary care provider, nor a laboratory confirmed positive COVID-19 test result in the respondent or a respondent's immediate family member were associated with hesitancy. Of note, health care workers were equally represented in both the hesitant and the non-hesitant cohort (19.7% vs 18.6%, p=0.06).

Multivariable logistic regression modeling (Figure 1) Regarding perspectives towards vaccination science ( Table 3) , those identified as vaccine hesitant were less likely to agree with the statements "vaccines are effective in preventing disease spread/infection" (52.5% vs. 89.2%, p<0.001) and "face masks work to slow the spread of COVID," (72.4% vs. 91.9%, p<0.001). Conversely, the vaccine hesitant group were less likely to disagree with the statements, "vaccines are founded on false science" (44.1% vs. 82.6%, p<0.001), "vaccines can cause detrimental health issues" (11.1% vs. 46.7%, p<0.001), and "the best way to beat COVID is by having most people get the infection rather than get vaccinated" (56.3% vs. 77.8%, p<0.001). The vaccine hesitant group exhibited lower levels of trust in information from both government (39.6% vs.

78.9%, p<0.001) and traditional news sources (32.0% vs. 51.4%, p<0.001). Levels of trust in social media were low for both hesitant and willing groups (10.6% vs. 12.4%, p=0.39). Among the vaccine hesitant group, the most trusted source of health information was friends and family (51.1%).

This article is protected by copyright. All rights reserved Those willing to accept a COVID-19 vaccine were more likely to report being influenced to accept the vaccine by any one of the presented scenarios, including encouragement from their doctor or family, increased vaccine safety data, or positive experience of friends receiving the vaccine ( Table 3) . The scenarios most influencing the hesitant group to accept a vaccine were, "there is new scientific data showing no long-term side effects -6 months or more" (39.5% vs. 75.8%, p<0.001) and "a large study comes out showing no side effects in a large cohort of people you relate with" (38.3% vs. 76.1%, p<0.001). The degree of influence from an admired celebrity's successful vaccination ranked lower than other presented scenarios for both hesitant and willing groups (12.2% vs. 30.9%, respectively, p<0.001).

In a study of an ED-based adult patient cohort at two academic medical centers, we found a high degree of vaccine hesitancy, especially among younger and Black patients. Our assessment of health information perspectives among the hesitant suggests that governmental agencies are less wellreceived as information sources compared to friends or family, an important finding that suggests that government informational campaigns may have limited success in reaching such populations. Our work represents the first ED-based study of COVID-19 vaccine hesitancy to explore patient perspectives on vaccination science and trusted information sources. It is important to note that our study was largely conducted before the emergence of the COVID-19 delta variant in the United States; whether the rapid spread of this variant has impacted patient perspectives on vaccination remains unknown.

This work extends the recent findings of Rodriguez et al., 6 the only other ED-based survey of vaccine hesitancy. In that study, overall hesitancy was 39% (compared to 31.6% in our cohort) and was also more prevalent among younger and minority patients. The authors found that stated reasons for hesitancy included concerns about safety and lack of vaccine information, which was also found in our cohort. In the work of Rodriguez et al., the employment status of patients is unknown;

remarkably, in our cohort health care workers were a sizable portion of the hesitant population (19.7%). We also found no significant association between hesitancy and connection to primary care

This article is protected by copyright. All rights reserved providers, a finding that differed from the work of Rodriguez et al., who found that lack of availability of primary care was associated with hesitancy.

The incidence and high transmissibility of the COVID-19 delta variant has presented new public health concerns, prompting the reinstatement of mask mandates, social distancing guidelines, and other precautions in some communities. Public health officials have cited unvaccinated and vaccine-hesitant Americans as the primary group responsible for affecting levels of community immunity, presenting increased risk to others, and ultimately determining the future course of the pandemic. [13] [14] [15] [16] Our work underscores that hesitancy is a broad problem that affects minority populations and may be rooted in concerns about vaccine safety and other potentially addressable issues. Increased levels of vaccine hesitancy were found in Black respondents, a group subject to disproportionate impact in terms of COVID-19 infection rates and fatalities. Within this group, younger age increased the odds of hesitancy by a significant margin. These data more precisely identify the vaccine-hesitant community in urban ED populations, with the potential to inform and help tailor mitigation efforts for larger populations.

A long history of racial injustice in healthcare has left Black populations skeptical and with high levels of mistrust in U.S. health systems. The consequences of these inequities have been realized once again during the COVID-19 pandemic in the form of heightened transmission, mortality and now, disproportionately low levels of vaccination among Blacks. 3, 15 Recent research has demonstrated the impact of trusted ambassadors such as Black physicians, faith leaders, and other community members in facilitating conversations regarding hesitancy and has shown high levels of success driving vaccine uptake when these methods are employed. [15] [16] [17] Despite reluctance to receive a COVID-19 vaccine, 50% of hesitant respondents agreed that vaccines are efficacious, adding to existing evidence that suggests hesitancy is COVID-19 vaccine specific and not necessarily the product of more generally held beliefs surrounding vaccines.

Responses to Likert statements regarding the scientific foundation of available COVID-19 vaccines suggest a lack of understanding for vaccine science and may reflect the effects of misinformation disseminated by trusted sources. This adds probable merit to additional educational initiatives, which may have more definite impact in point-of-care situations such as the ED. Specifically for Black

This article is protected by copyright. All rights reserved patients, provider intervention has been suggested as an effective measure for reducing COVID-19 vaccine hesitancy. 18 Successful communication with hesitant audiences will require the strategic use of trusted channels. Lack of trust in government and traditional media sources was elevated for the vaccinehesitant, while friends and family ranked the highest in terms of trustworthiness (51%) among the presented sources. While this presents the natural challenges associated with word-of-mouth communications and inherent biases in information communicated by loved ones, the findings also suggest that concentrated micro-targeting strategies may be more successful than large-scale appeals from government agencies, officials, or other sources. The findings of this study also suggest that social media is likely not an effective agent of change, with both vaccine-hesitant and willing groups reporting very low levels of trust in the medium. Social media platforms have also been found to be associated with the distribution of misinformation and responsible for driving vaccine hesitancy. 19 The study also documents expressed concerns from the hesitant group regarding the potential for detrimental health effects caused by COVID-19 vaccines. This finding aligns with existing research on the influence of perceived side effects on hesitancy in ED populations 6 and is likely associated with the hesitant group's increased agreement that immunity is better achieved via infection than via vaccination. Increased levels of hesitancy were also detected in younger females, irrespective of race. This may evidence ongoing concerns held by some regarding the vaccines' effects on fertility, despite a lack of evidence to suggest any such association or heightened risk. 20 The fraction of healthcare workers in the hesitant group (19.7%) presents additional concerns in terms of hospital operations and challenges to mitigate hesitancy attributed to a lack of vaccine information. Healthcare workers are likely to have among the greatest access to current vaccine science, yet their level of hesitancy suggests that existing channels of communication may not be resonating with them. Hesitancy among healthcare workers also poses the threats of workforce disruption and further disease spread. An outbreak among unvaccinated healthcare workers, regardless of their unique roles, has the potential to seriously disrupt hospital operations, impede patient care, and/or risk transmission of the virus to patients during asymptomatic or incubation phases. This in turn threatens patients, guests, other staff, and the credibility of the associated institution.

This article is protected by copyright. All rights reserved Among those willing to accept vaccination, 90% said they would be willing to receive the vaccine in the ED. This suggests the powerful role the Emergency Department can play in improving vaccination rates, especially among those who may not otherwise have access to healthcare. 21 Furthermore, by better understanding the reasons for vaccine hesitancy and vaccine misinformation, as explored in this study, EDs will be better equipped to help address vaccine hesitancy, among both patients and health care personnel. 22 Vaccine hesitancy also risks aggravating barriers to healthcare access for vaccinated persons seeking care for non-COVID-19 related illness, with more drastic effects on traditionally underserved populations. Hospitals fielding a high volume of COVID-19 patients have been forced to suspend elective procedures, preventative, and other care for non-COVID-19 illness. With unvaccinated Americans driving hospitalizations, hospitals may be forced to suspend these services once again.

This evidences the increased need and motivation for hospitals and health systems to understand and attempt to mitigate reasons for vaccine hesitancy in their localities, with successful interventions having the possible adjunct effect of improving non-COVID-19 disease outcomes.

This project is subject to limitations associated with survey-based research. The findings are drawn from a discrete geographic region and may not be generalizable. We did not ascertain the geographic distribution of participants regarding urban versus rural residence; however, the great majority of all patients presenting to our EDs are from the greater Philadelphia metropolitan area (i.e., non-rural origin). As this represented a longitudinal survey over time, secular trends of media influence and vaccine availability may have influenced patients over the course of the study; in addition, the rapid spread of the delta variant occurred largely after our study was completed. As with any survey study, self-reporting may be subject to a variety of biases, including social desirability and recall bias. We did not perform follow-up with any subjects to determine if they received vaccination at some later point. 

Ten health issues WHO will tackle this year

Demographic characteristics of people receiving covid-19 vaccinations in the United States

Influenza in the emergency department: vaccination, diagnosis, and treatment: clinical practice paper approved by American academy of emergency medicine clinical guidelines committee

Emergency department-based COVID-19 vaccination: Where do we stand?

The rapid evaluation of covid-19 vaccination in emergency departments for underserved patients study

Factors associated with us adults' likelihood of accepting covid-19 vaccination

Determinants of COVID-19 vaccine acceptance in the US

Accepted Article This article is protected by copyright. All rights reserved

Covid-19 vaccination hesitancy in the united states: a rapid national assessment

A global survey of potential acceptance of a COVID-19 vaccine

COVID-SCORE: A global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10)

A consensus-based checklist for reporting of survey studies (CROSS)

America is now in the hands of the vaccine-hesitant. The Atlantic

Unvaccinated clusters allow Covid to mutate and put everyone at risk, doctor says

Operationalizing Equity: A rapid-cycle innovation approach to covid-19 vaccination in black neighborhoods. NEJM Catalyst Innovations in Care Delivery

All rights reserved 16. South E. Opinion | I'm a Black doctor who didn't trust the Covid vaccine. Here's what changed my mind

Vaccine hesitancy is common among Black healthcare workers

We're trying to resolve it

Understanding drivers of coronavirus disease 2019 vaccine hesitancy among blacks

Social media and vaccine hesitancy

Preliminary findings of mrna covid-19 vaccine safety in pregnant persons

Emergency department-based COVID-19 vaccination: where do we stand?

Vaccination rates and acceptance of SARS-CoV-2 vaccination among U.S. emergency department health care personnel

The authors wish to thank the University of Pennsylvania Emergency Medicine Academic Associates program participants, who proctored the survey process.

This study identified a high degree of COVID-19 vaccine hesitancy among ED patients, with selfreported barriers related to worries about vaccine safety among other concerns. Hesitant patients were less likely to trust government sources of health information than friends/family. Further work will be required to test ED-based interventions to mitigate vaccine hesitancy in select populations.

This article is protected by copyright. All rights reserved